Initial Results of PX-171-003, An Open-Label, Single-Arm, Phase II Study of Carfilzomib (CFZ) in Patients with Relapsed and Refractory Multiple Myeloma (MM)

被引：0

作者：

Jagannath, Sundar ^{[1
]}

Vij, Ravi ^{[2
]}

Stewart, A. Keith ^{[3
]}

Somlo, George ^{[4
]}

Jakubowiak, Andrzej ^{[5
]}

Reiman, Tony ^{[6
]}

Trudel, Suzanne ^{[7
]}

Taylor, Jessica ^{[8
]}

Fuhrman, Diana ^{[8
]}

Cruickshank, Scott ^{[8
]}

Schwartz, Richard ^{[8
]}

Kunkel, Lori ^{[8
]}

Siegel, David ^{[9
]}

机构：

[1] St Vincents Comp Canc Ctr, New York, NY USA

[2] Washington Univ, Sch Med, St Louis, MO USA

[3] Mayo Clin, Scottsdale, AZ USA

[4] City Hope Natl Med Ctr, Duarte, CA 91010 USA

[5] Univ Michigan, Ctr Comprehens Canc, Ann Arbor, MI 48109 USA

[6] Cross Canc Inst, Edmonton, AB T6G 1Z2, Canada

[7] Princess Margaret Hosp, Toronto, ON M4X 1K9, Canada

[8] Proteolix Inc, Clin Operat, San Francisco, CA USA

[9] Hackensack Univ, Med Ctr, Hackensack, NJ USA

[10] MMRC, Norwalk, CT USA

来源：

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：319 / 319

页数：1